CYTKNasdaq SEC EDGAR

CYTOKINETICS INC

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA·FY end 12/31·CIK 1061983

Overview Financials Compensation Governance Insiders Filings

Net 180d

-$26.9M

0 buys / 46 sales

Open-market buys

0 transactions

Open-market sales

$26.9M

46 transactions

Cluster windows

0 buy / 4 sell

Insider transaction timeline

2-year window · 30 buys · 46 sales · dot size = transaction value

AcquisitionsSalesCluster window (≥2 sales / month)

Form 4 transactions

Showing 30 of 76

Date	Insider	Type	Shares	Value
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Exercise	11,333	$443.5K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Sale	11,333	-$875.5K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Exercise	3,500	$27.3K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Sale	3,500	-$270.8K
2026-05-05	WIERENGA WENDELL	Exercise	4,032	$50.0K
2026-05-05	WIERENGA WENDELL	Sale	4,032	-$302.4K
2026-05-05	HENDERSON JOHN T	Exercise	20,000	$152.2K
2026-05-05	HENDERSON JOHN T	Sale	20,000	-$1.5M
2026-05-05	Lee SungEVP, Chief Financial Officer	Sale	23,906	-$1.8M
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Exercise	11,333	$443.5K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Sale	11,333	-$875.5K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Exercise	3,500	$27.3K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Sale	3,500	-$270.8K
2026-05-05	WIERENGA WENDELL	Exercise	4,032	$50.0K
2026-05-05	WIERENGA WENDELL	Sale	4,032	-$302.4K
2026-05-05	HENDERSON JOHN T	Exercise	20,000	$152.2K
2026-05-05	HENDERSON JOHN T	Sale	20,000	-$1.5M
2026-05-05	Lee SungEVP, Chief Financial Officer	Sale	23,906	-$1.8M
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Exercise	15,857	$596.7K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Sale	15,857	-$1.0M
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Exercise	15,857	$596.7K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Sale	15,857	-$1.0M
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Exercise	15,000	$348.9K
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Sale	15,000	-$948.9K
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Exercise	15,000	$348.9K
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Sale	15,000	-$948.9K
2026-04-29	Blum Robert IPresident & CEO	Sale	7,500	-$447.1K
2026-04-29	Blum Robert IPresident & CEO	Sale	7,500	-$447.1K
2026-04-21	Malik Fady IbrahamEVP Research & Development	Exercise	3,500	$27.3K
2026-04-21	Malik Fady IbrahamEVP Research & Development	Sale	3,500	-$229.9K